Taris names Duddu president, CEO

> Taris Biomedical has named Sarma Duddu president and CEO and a member of the board of directors, effective immediately.
> Amgen has tapped Jonathan Peacock as CFO, effective Sept. 1. Release
> K-V Pharmaceutical has announced that Thomas McHugh has been appointed CFO, effective immediately.
> Spectrum Pharmaceuticals has named George Tidmarsh to the position of senior VP, chief scientific officer and head of R&D operations.
> Phage Pharmaceuticals has appointed David Jackson to the position of VP, operations planning.
> Keryx Biopharmaceuticals has appointed Joseph Feczko to its board of directors.
> Seaside Therapeutics has named Marc Beer, former CEO of ViaCell, Karen Dawes, president of Knowledge Decisions, and Steven Paul, former executive VP for science and technology of Eli Lilly, to its board of directors.

Add new comment

Images
More information
  • Files must be less than 2 MB.
  • Allowed file types: png gif jpg jpeg.
Documents
More information
  • Files must be less than 2 MB.
  • Allowed file types: zip rar.